These outcomes, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a singular approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-related Conditions. Identify your selection: Identify have https://paulb814cxq0.wikibestproducts.com/user